Head-to-head · Value Score
Alan Meds vs LIV by WellNow
Two GLP-1 deals, scored on the same six factors. Alan Meds lands a Value Score of 90, LIV by WellNow a 66. Here's who gives you the honest lower price — and where each one bites back.
Alan Meds
#7 · Grade A · Best Value
Est. first month
$99/mo
Save ~93% vs brand-nameLIV by WellNow
#306 · Grade C · Watch List
Est. first month
$279/mo
Save ~79% vs brand-nameThe verdict
Alan Meds takes it on Value Score, 90 to 66 — an est. $99/mo first month, with no teaser step-up baked in. LIV by WellNow isn't out of it: Patients in IL, IN, MI, NY, or PA wanting flat all-inclusive compounded semaglutide.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | Alan Meds | LIV by WellNow |
|---|---|---|
| Value Score | 90 (A) | 66 (C) |
| Est. first month | $99/mo | $279/mo |
| Save vs brand-name | ~93% | ~79% |
| Semaglutide | $99/mo | $279/mo |
| Tirzepatide | $145/mo | Not disclosed |
| Both molecules | Yes | No |
| Pricing | Flat — no step-up | Flat — no step-up |
| Coverage | All 50 states | 5 states |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
Alan Meds
Double-digit semaglutide ($99) and a $145 tirzepatide, both nationwide, with an oral route for the needle-shy.
Why it's a deal
- $99 flat semaglutide and a low $145 tirzepatide
- Available in all 50 states
- Offers an oral/sublingual route
The fine print
- Not LegitScript-certified — do your own pharmacy diligence
- Newer operator with a thin public track record
LIV by WellNow
LIV by WellNow is the telehealth weight-management arm of WellNow Urgent Care, offering compounded semaglutide for weight loss.
Why it's a deal
- Flat $279/month covers medication, supplies, and unlimited virtual visits
- Backed by established WellNow Urgent Care brand
- Board-certified online medical providers
- Same-day approval and monthly home delivery
- Transparent all-inclusive pricing with no hidden fees
The fine print
- Compounded semaglutide is not FDA-approved or evaluated
- Only available in five states (IL, IN, MI, NY, PA)
- No tirzepatide option offered
- Insurance not accepted for compounded semaglutide
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores Alan Meds is ranked on the Alan Meds alternatives board, and the same list for the other side is on alternatives to LIV by WellNow.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.